It looks like Jon Jones will not be seeing any fights in the Octagon soon- for a whole year to be exact- after being handed a suspension by the United States Anti-Doping Agency (USADA) for doping violations.
“USADA announced today that an independent three-member arbitration panel from McLaren Global Sports Solutions, Inc. (MGSS) has rendered its decision in the case of UFC® athlete, Jon Jones, of Rochester, N.Y., and determined that Jones should receive the maximum one-year period of ineligibility for his anti-doping policy violation,” opened the official press release of the USADA.
The violation, which can be traced all the way back to June was based on the results of an out of competition test prior to Jones’s supposed UFC 200 match. According to the results, the light-heavyweight fighter tested positive for substances clomiphene and letrozole which are banned by the USADA.
Meanwhile, the interim champ claimed that he had not intended to take the substances, and accidentally ingested the chemicals believing it was a sexual-enhancement pill. Unfortunately, though, the pills were tainted and resulted in Jones’s testing positive for the banned substances.
Despite the USADA confirming that he “is not a drug cheat,” the decision was still obviously not the outcome Jon Jones was hoping for.
“Although I was hopeful for a better outcome in the USADA ruling today, I am very respectful of the process in which they allowed me to defend myself,” shared Jones in his statement. “I am pleased that in USADA’s investigation they determined I was ‘not a cheater of the sport.’ I have worked hard in and outside of the octagon to regain my image and my fighting career and will take these next eight months to continue my training and personal growth both as a man and a athlete.”
There is still a bit of light in the tunnel, as the decision is retroactive, meaning the start of Jones’s suspension will be traced back to his drug test, back in June. This means we can (hopefully) see Jon Jones back in the Octagon by July 2017.
Photo Courtesy: ericdwheeler/ Flickr